Literature DB >> 17180617

Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice.

Tilly Chang1, Urs Meyer, Joram Feldon, Benjamin K Yee.   

Abstract

RATIONALE: Pre-exposure to either one of the two to-be-associated stimuli alone is known to reduce the efficiency of the learning of their association when they are subsequently paired explicitly. In classical conditioning, pre-exposure to the conditioned stimulus (CS) gives rise to latent inhibition (LI); and pre-exposure to the unconditioned stimulus (US) results in the US pre-exposure effect (USPEE). Considerable evidence supports an important role of central dopamine in the regulation and modulation of LI; it has been suggested that the USPEE may be similarly controlled by dopamine, but this parallelism has only been directly demonstrated in the conditioned taste aversion paradigm.
OBJECTIVE: The present study tested this hypothesis by comparing the efficacy of systemic amphetamine treatment to affect the expression of LI and the USPEE in a two-way active avoidance paradigm.
METHODS: C57BL/6 male mice were tested in active avoidance using a tone CS and a foot-shock US. Twenty-four hours before, they were pre-exposed to 100 presentations of the CS or the US, or to the test apparatus only. Amphetamine (2.5 mg/kg) or saline was administered before stimulus pre-exposure and conditioned avoidance test, in which the mice learned to avoid the shock by shuttling in response to the tone.
RESULTS: Amphetamine disrupted both stimulus pre-exposure effects, thus, lending further support to the hypothesis that the USPEE is similar to LI in its sensitivity to dopamine receptor agonist. Hence, the USPEE paradigm may represent a valuable addition to the study of dopamine-sensitive processes of selective learning currently implicated in LI and Kamin blocking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180617     DOI: 10.1007/s00213-006-0649-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  67 in total

Review 1.  Perplexing effects of hippocampal lesions on latent inhibition: a neural network solution.

Authors:  C V Buhusi; J A Gray; N A Schmajuk
Journal:  Behav Neurosci       Date:  1998-04       Impact factor: 1.912

2.  Drug-preexposure effects in flavor-aversion learning: associative interference by conditioned environmental stimuli.

Authors:  J D Batson; P J Best
Journal:  J Exp Psychol Anim Behav Process       Date:  1979-07

3.  Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Authors:  I Baruch; D R Hemsley; J A Gray
Journal:  J Nerv Ment Dis       Date:  1988-10       Impact factor: 2.254

Review 4.  The schizophrenic experience: taken out of context?

Authors:  David R Hemsley
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

Review 5.  Disruption of the Kamin blocking effect in schizophrenia and in normal subjects following amphetamine.

Authors:  S H Jones; D Hemsley; S Ball; A Serra
Journal:  Behav Brain Res       Date:  1997-10       Impact factor: 3.332

6.  Role of stimulus locale on strain differences in active avoidance after scopolamine of D-amphetamine treatment.

Authors:  H Anisman
Journal:  Pharmacol Biochem Behav       Date:  1976-01       Impact factor: 3.533

Review 7.  Latent inhibition in humans: data, theory, and implications for schizophrenia.

Authors:  R E Lubow; J C Gewirtz
Journal:  Psychol Bull       Date:  1995-01       Impact factor: 17.737

8.  Antidepressant-like effects of dopamine agonists in an animal model of depression.

Authors:  R Muscat; M Papp; P Willner
Journal:  Biol Psychiatry       Date:  1992-05-01       Impact factor: 13.382

Review 9.  Dopamine and depression: a review of recent evidence. I. Empirical studies.

Authors:  P Willner
Journal:  Brain Res       Date:  1983-12       Impact factor: 3.252

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  7 in total

1.  A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment.

Authors:  Tatiana Lipina; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2009-12-16       Impact factor: 4.530

2.  Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?

Authors:  Mariana Bendlin Calzavara; Wladimir Agostini Medrano; Raquel Levin; Sonia Regina Kameda; Monica Levy Andersen; Sergio Tufik; Regina Helena Silva; Roberto Frussa-Filho; Vanessa Costhek Abílio
Journal:  Schizophr Bull       Date:  2008-02-16       Impact factor: 9.306

3.  Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice.

Authors:  Philipp Singer; Joram Feldon; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2009-05-30       Impact factor: 4.530

4.  The effects of breeding protocol in C57BL/6J mice on adult offspring behaviour.

Authors:  Claire J Foldi; Darryl W Eyles; John J McGrath; Thomas H J Burne
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

5.  Sex differences in avoidance behavior after perceiving potential risk in mice.

Authors:  Sayaka Yokota; Yusuke Suzuki; Keigo Hamami; Akiko Harada; Shoji Komai
Journal:  Behav Brain Funct       Date:  2017-05-05       Impact factor: 3.759

6.  D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors.

Authors:  C Bay-Richter; M J O'Callaghan; N Mathur; C M P O'Tuathaigh; D M Heery; K C F Fone; J L Waddington; P M Moran
Journal:  Neuropsychopharmacology       Date:  2013-02-19       Impact factor: 7.853

7.  Sex-specific positive and negative consequences of avoidance training during childhood on adult active avoidance learning in mice.

Authors:  Almuth Spröwitz; Jörg Bock; Katharina Braun
Journal:  Front Behav Neurosci       Date:  2013-10-16       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.